Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
10/1995
10/25/1995EP0678121A1 Methods and reagents for inhibiting furin endoprotease
10/25/1995EP0678099A1 New peptides
10/25/1995EP0678098A1 Pyrrolidine and thiazolidine derivatives, their preparation and drugs containing same
10/25/1995EP0678089A1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders.
10/25/1995EP0678088A1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders.
10/24/1995US5461035 Short peptides with insulin activity
10/24/1995CA1337407C Dimeric peptides having a stimulatory effect on haemopoiesis and a process for their preparation
10/19/1995WO1995027782A1 Peptide production as fusion protein in transgenic mammal milk
10/19/1995WO1995027729A1 Opiate receptor ligands
10/19/1995WO1995027728A1 Peptides
10/19/1995WO1995027727A2 Process for peptide segment condensation
10/19/1995WO1995017418A3 NOVEL INTERMEDIATES FOR THE SYNTHESIS OF L-ASPARTYL-D-α-AMINOALKANOYL-(S)-N-α-ALKYLBENZYL AMIDES USEFUL AS ARTIFICIAL SWEETENERS
10/19/1995CA2187173A1 Peptide production as fusion protein in transgenic mammal milk
10/19/1995CA2186605A1 Process for peptide segment condensation
10/18/1995EP0677531A1 Derivates of boronic peptides, preparation and use thereof in therapy
10/18/1995EP0677525A1 Aminoboronic acid derivatives, their preparation as intermediates in syntheses
10/18/1995EP0677292A1 Anti-viral and anti-cancer agents
10/18/1995EP0677060A1 Peptide inhibitors of cell adhesion
10/18/1995EP0677059A1 Endothelin converting enzyme inhibitors
10/18/1995EP0677043A1 Platelet aggregation inhibiting compounds
10/17/1995US5459156 Angiotensin converting enzyme inhibitors, hypotensive, atherosclerosis
10/17/1995US5459036 Extracellular signal-regulated kinase, sequences, and methods of production and use
10/13/1995CA2146833A1 Boronic peptides derivatives; process for preparing the same and their use as therapeutic agents
10/13/1995CA2146832A1 Aminoboronic acid derivatives; process for preparing the same and their use as synthesis intermediates
10/12/1995WO1995026978A1 Cyclic peptide and process for producing the same
10/12/1995WO1995026958A1 Pyrimidinyl derivatives as interleukin inhibitors
10/12/1995WO1995022991A3 Block copolymers
10/12/1995DE4410881A1 Substd. heterocyclic carboxylic acid amides and their prepn.
10/11/1995EP0676411A2 Peptides and pseudopeptides derived from tachykinine, their preparation and their pharmaceutical compositions
10/11/1995EP0675902A1 Endothelin antagonists
10/11/1995EP0675901A1 Difluoro-pentapeptide derivative anti-inflammatory agents
10/11/1995EP0675900A1 Antibiotics ge 37468 a, b and c
10/11/1995EP0675899A1 NOVEL INHIBITORS OF FACTOR Xa
10/11/1995EP0675898A1 Use of molecularly imprinted polymers for stereo- and/or regioselective synthesis
10/10/1995US5457196 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
10/10/1995US5457180 Methods for producing linear thiopeptides using an amino acid ortho amino thioanilide compound
10/10/1995US5457114 Antithrombin; antithrombotic, enzyme resistance, tolerability
10/05/1995WO1995026360A1 Antagonists of endothelin receptors
10/05/1995WO1995021252A3 Wd-40-derived peptides and uses thereof
10/05/1995CA2183767A1 Antagonists of endothelin receptors
10/04/1995EP0675112A1 Imidazole-containing inhibitors of farnesyl protein transferase
10/04/1995EP0675101A1 Transesterification and other conversion reactions of acid derivatives with an amidine base
10/04/1995EP0674655A1 Acyclic peptide analogs of the atrial natriuretic peptide, process for producing the same and their use
10/04/1995EP0674654A1 Acyclic, sulphureous peptides as analogs of the atrial natriuretic peptide
10/04/1995EP0674653A1 Therapeutic compounds suitable for the treatment of diseases connected with glutathione deficiency, process for their preparation, and pharmaceutical compositions containing same
10/04/1995EP0674652A1 Dolostatin analog
10/04/1995EP0674632A1 Aminoacid derivatives of heterocycles as protein kinase c inhibitors
10/04/1995CN1109468A Sulfonamido heterocyclic thrombin inhibitors
10/03/1995US5455259 Compounds for the treatment of neurodegenerative disorders
10/03/1995US5455242 Analgesics, hypotensive or cardiotonic agents, diuretics, antidepressants or suppressors of vascular response after angioplasty
10/03/1995US5455230 Delta opioid receptor antagonists and their use as analgesic agents
10/03/1995US5455229 A tripeptide based on a alanine, proline and arginine derivative; protease inhibitors; myocardial infarctions
10/01/1995CA2146059A1 Imidazole-containing inhibitors of farnesyl protein transferase
09/1995
09/28/1995WO1995025749A2 Eating suppressant peptides
09/28/1995WO1995025728A1 Taxane derivatives with antitumor activity
09/28/1995WO1995025720A1 Piperidyl-4-substituted thyrosine derivatives as scintigraphic imaging agents for the diagnosis of thrombosis
09/28/1995WO1995025533A1 PROTEASOME REGULATION OF NF-λB ACTIVITY
09/28/1995WO1995025532A1 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic aminoacetylmercapto derivatives
09/28/1995WO1995025530A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
09/28/1995CA2186006A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
09/28/1995CA2185450A1 Eating suppressant peptides
09/27/1995EP0673936A1 Antithrombotic agents
09/27/1995EP0673921A1 Process for recovering L-phenylalanine
09/27/1995EP0673385A1 Mammalian gap-43 compositions and methods of use
09/27/1995EP0673234A1 Tissue protective and regenerative compositions
09/26/1995US5453488 Amino-substituted heterocycles as renin inhibitors
09/26/1995US5453440 Peptide mimics useful as platelet aggregation inhibitors
09/26/1995US5453438 Hydroxamic acid based collagenase inhibitors
09/26/1995US5453430 1-[2-(arylsulphonylamino)-1-oxoethyl]piperidine derivatives, their preparation and their therapeutic application
09/25/1995CA2145454A1 Process for recovering l-phenylalanine
09/25/1995CA2143588A1 Inhibitors of farnesyl protein transferase
09/21/1995WO1995025118A2 Inhibitors of sh2 domain interactions
09/21/1995WO1995025092A1 Inhibitors of farnesyl-protein transferase
09/21/1995WO1995025086A1 Isoprenyl transferase inhibitors
09/21/1995WO1995024916A1 Retropeptides, antibodies thereto, and uses thereof for vaccination and in vitro diagnosis
09/21/1995WO1995024914A1 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
09/21/1995WO1995024897A1 Anti-viral and anti-cancer agents
09/21/1995CA2185817A1 Anti-viral and anti-cancer agents
09/21/1995CA2185553A1 Inhibitors of farnesyl-protein transferase
09/21/1995CA2185441A1 Isoprenyl transferase inhibitors
09/21/1995CA2185326A1 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
09/20/1995EP0672701A1 PNA-synthesis using a base labile aminoprotecting group
09/20/1995EP0672678A1 Azapeptide derivative
09/20/1995EP0672665A1 Antithrombotic agents
09/20/1995EP0672659A1 Antithrombotic agents
09/20/1995EP0672658A1 Antithrombotic agents
09/20/1995EP0672657A1 Antithrombotic agents
09/20/1995EP0672648A1 Threo-3-amino-2-hydroxypentanoic acid and threo (2R,3S), (2S,3R)-3-(p-methoxy-benzyloxycarbonyl) amino-2-hydroxy-pentanoic acid
09/20/1995EP0672132A1 Receptor internalization signals
09/20/1995EP0672059A1 CYCLIC COMPOUNDS LINKED BY A HETEROCYCLIC RING USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa
09/20/1995EP0672054A1 A novel molecule which inhibits neuropeptide tyrosine biological function
09/20/1995EP0671931A1 Hemoregulatory peptides
09/20/1995EP0671924A1 Digitalis-like compounds
09/20/1995CN1108863A Amino acid amide derivative, agrohorticultural bactericide, and production process
09/14/1995WO1995024501A1 Compositions for the inhibition of tnf formation and uses thereof
09/14/1995WO1995024421A1 Peptide derivative
09/14/1995WO1995024420A1 A polymorph of aspartame and process for the preparation thereof
09/14/1995CA2185212A1 Peptide derivatives
09/14/1995CA2185162A1 Compositions for the inhibition of tnf formation and uses thereof
09/13/1995EP0671390A2 Antithrombotic agents
1 ... 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 ... 307